MRSA: A global burden

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem: Farmakológiai Intézethu_HU
dc.contributor.authorFarah, Amir
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai tanszékhu_HU
dc.contributor.opponentdeptDebreceni Egyetem: Farmakológiai Intézethu_HU
dc.date.accessioned2014-07-29T12:48:28Z
dc.date.available2014-07-29T12:48:28Z
dc.date.created2014
dc.description.abstractStaphylococcal bacteremia or sepsis is one of the most hazardous, serious and most life threatening bacterial infections worldwide. The risk is increased in those individuals with pre-existing disorders such as those disorders affecting the immune system, certain drug therapies, diagnostic and therapeutic procedures, and a high number of hospitalizations. More specific risk factors include the use of a central vascular catheter (CVC), urinary catheters, nasogastric tubes, parenteral nutrition, tracheostomies, mechanical ventilation, and previous antibiotic therapy. Methicillin-resistant Staphylococcus aureus (MRSA) is a term used for those Staphylococcus aureus strains which possess resistance to a variety of penicillins.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent30hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/195469
dc.language.isoenhu_HU
dc.subjectMRSAhu_HU
dc.subjectAntibioticshu_HU
dc.subject.dspacePharmacologyhu_HU
dc.subject.dspaceInfectologyhu_HU
dc.titleMRSA: A global burdenhu_HU
dc.title.translatedMRSA: A global burdenhu_HU
Fájlok